Literature DB >> 22267729

Curcumin prevents aggregation in α-synuclein by increasing reconfiguration rate.

Basir Ahmad1, Lisa J Lapidus.   

Abstract

α-Synuclein is a protein that is intrinsically disordered in vitro and prone to aggregation, particularly at high temperatures. In this work, we examined the ability of curcumin, a compound found in turmeric, to prevent aggregation of the protein. We found strong binding of curcumin to α-synuclein in the hydrophobic non-amyloid-β component region and complete inhibition of oligomers or fibrils. We also found that the reconfiguration rate within the unfolded protein was significantly increased at high temperatures. We conclude that α-synuclein is prone to aggregation because its reconfiguration rate is slow enough to expose hydrophobic residues on the same time scale that bimolecular association occurs. Curcumin rescues the protein from aggregation by increasing the reconfiguration rate into a faster regime.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22267729      PMCID: PMC3308736          DOI: 10.1074/jbc.M111.325548

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Evidence for a partially folded intermediate in alpha-synuclein fibril formation.

Authors:  V N Uversky; J Li; A L Fink
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

2.  Measuring dynamic flexibility of the coil state of a helix-forming peptide.

Authors:  Lisa J Lapidus; William A Eaton; James Hofrichter
Journal:  J Mol Biol       Date:  2002-05-24       Impact factor: 5.469

Review 3.  Inhibitors of alpha-synuclein oligomerization and toxicity: a future therapeutic strategy for Parkinson's disease and related disorders.

Authors:  Dena A M Amer; G Brent Irvine; Omar M A El-Agnaf
Journal:  Exp Brain Res       Date:  2006-05-30       Impact factor: 1.972

4.  Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.

Authors:  Fusheng Yang; Giselle P Lim; Aynun N Begum; Oliver J Ubeda; Mychica R Simmons; Surendra S Ambegaokar; Pingping P Chen; Rakez Kayed; Charles G Glabe; Sally A Frautschy; Gregory M Cole
Journal:  J Biol Chem       Date:  2004-12-07       Impact factor: 5.157

5.  Identification of a helical intermediate in trifluoroethanol-induced alpha-synuclein aggregation.

Authors:  Valerie L Anderson; Trudy F Ramlall; Carla C Rospigliosi; Watt W Webb; David Eliezer
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-14       Impact factor: 11.205

6.  Interaction of alphaS1-casein with curcumin and its biological implications.

Authors:  Athahalli H Sneharani; Sridevi Annapurna Singh; A G Appu Rao
Journal:  J Agric Food Chem       Date:  2009-11-11       Impact factor: 5.279

7.  Curcumin inhibits FtsZ assembly: an attractive mechanism for its antibacterial activity.

Authors:  Dipti Rai; Jay Kumar Singh; Nilanjan Roy; Dulal Panda
Journal:  Biochem J       Date:  2008-02-15       Impact factor: 3.857

8.  Structural and mechanistic basis behind the inhibitory interaction of PcTS on alpha-synuclein amyloid fibril formation.

Authors:  Gonzalo R Lamberto; Andrés Binolfi; María L Orcellet; Carlos W Bertoncini; Markus Zweckstetter; Christian Griesinger; Claudio O Fernández
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-30       Impact factor: 11.205

Review 9.  Protein aggregation and neurodegenerative disease.

Authors:  Christopher A Ross; Michelle A Poirier
Journal:  Nat Med       Date:  2004-07       Impact factor: 53.440

10.  Conformational properties of unfolded HypF-N.

Authors:  Yujie Chen; Claudia Parrini; Niccolò Taddei; Lisa J Lapidus
Journal:  J Phys Chem B       Date:  2009-12-17       Impact factor: 2.991

View more
  51 in total

1.  Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric form.

Authors:  Timothy J Collier; Kinshuk R Srivastava; Craig Justman; Tom Grammatopoulous; Birgit Hutter-Paier; Manuela Prokesch; Daniel Havas; Jean-Christophe Rochet; Fang Liu; Kevin Jock; Patrícia de Oliveira; Georgia L Stirtz; Ulf Dettmer; Caryl E Sortwell; Mel B Feany; Peter Lansbury; Lisa Lapidus; Katrina L Paumier
Journal:  Neurobiol Dis       Date:  2017-07-12       Impact factor: 5.996

Review 2.  Clinical development of curcumin in neurodegenerative disease.

Authors:  Shuxin Hu; Panchanan Maiti; Qiulan Ma; Xiaohong Zuo; Mychica R Jones; Greg M Cole; Sally A Frautschy
Journal:  Expert Rev Neurother       Date:  2015-06       Impact factor: 4.618

3.  Biochemical stabilization of glucagon at alkaline pH.

Authors:  Nicholas Caputo; Melanie A Jackson; Jessica R Castle; Joseph El Youssef; Parkash A Bakhtiani; Colin P Bergstrom; Julie M Carroll; Matthew E Breen; Gerald L Leonard; Larry L David; Charles T Roberts; W Kenneth Ward
Journal:  Diabetes Technol Ther       Date:  2014-06-26       Impact factor: 6.118

4.  Molecular basis for preventing α-synuclein aggregation by a molecular tweezer.

Authors:  Srabasti Acharya; Brian M Safaie; Piriya Wongkongkathep; Magdalena I Ivanova; Aida Attar; Frank-Gerrit Klärner; Thomas Schrader; Joseph A Loo; Gal Bitan; Lisa J Lapidus
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

5.  Protective effects of curcumin against rotenone-induced rat model of Parkinson's disease: in vivo electrophysiological and behavioral study.

Authors:  L V Darbinyan; L E Hambardzumyan; K V Simonyan; V A Chavushyan; L P Manukyan; S A Badalyan; N Khalaji; V H Sarkisian
Journal:  Metab Brain Dis       Date:  2017-07-10       Impact factor: 3.584

6.  Curcumin ameliorates the neurodegenerative pathology in A53T α-synuclein cell model of Parkinson's disease through the downregulation of mTOR/p70S6K signaling and the recovery of macroautophagy.

Authors:  Tian-Fang Jiang; Ying-Jie Zhang; Hai-Yan Zhou; Hong-Mei Wang; Li-Peng Tian; Jun Liu; Jian-Qing Ding; Sheng-Di Chen
Journal:  J Neuroimmune Pharmacol       Date:  2013-01-17       Impact factor: 4.147

7.  Effects of 2-amino-8-hydroxyquinoline interaction on the conformation of physiological isomers of human serum albumin.

Authors:  Sonali M Shiriskar; Neeraj Agarwal; Raghuvir R S Pissurlenkar; Basir Ahmad
Journal:  Eur Biophys J       Date:  2015-03-12       Impact factor: 1.733

Review 8.  α-Synuclein oligomers and clinical implications for Parkinson disease.

Authors:  Lorraine V Kalia; Suneil K Kalia; Pamela J McLean; Andres M Lozano; Anthony E Lang
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

9.  Effects of Mutations on the Reconfiguration Rate of α-Synuclein.

Authors:  Srabasti Acharya; Shreya Saha; Basir Ahmad; Lisa J Lapidus
Journal:  J Phys Chem B       Date:  2015-12-04       Impact factor: 2.991

10.  Monomer Dynamics of Alzheimer Peptides and Kinetic Control of Early Aggregation in Alzheimer's Disease.

Authors:  Srabasti Acharya; Kinshuk R Srivastava; Sureshbabu Nagarajan; Lisa J Lapidus
Journal:  Chemphyschem       Date:  2016-09-15       Impact factor: 3.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.